Entrada Therapeutics, Inc. - Common Stock, par value $0.0001 per share (TRDA)

CUSIP: 29384C108

Q3 2024 13F Holders as of 30 Sep 2024

Type / Class
Equity / Common Stock, par value $0.0001 per share
Shares outstanding
38,346,880
Total 13F shares
30,099,996
Share change
+302,753
Total reported value
$481,057,545
Put/Call ratio
48%
Price per share
$15.98
Number of holders
97
Value change
+$6,089,620
Number of buys
62
Number of sells
26

Quarterly Holders Quick Answers

What is CUSIP 29384C108?
CUSIP 29384C108 identifies TRDA - Entrada Therapeutics, Inc. - Common Stock, par value $0.0001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Entrada Therapeutics, Inc. - Common Stock, par value $0.0001 per share (TRDA) as of Q3 2024

As of 30 Sep 2024, Entrada Therapeutics, Inc. - Common Stock, par value $0.0001 per share (TRDA) was held by 97 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 30,099,996 shares. The largest 10 holders included BAKER BROS. ADVISORS LP, MPM ASSET MANAGEMENT LLC, 5AM Venture Management, LLC, PRICE T ROWE ASSOCIATES INC /MD/, BlackRock, Inc., FMR LLC, JANUS HENDERSON GROUP PLC, VANGUARD GROUP INC, WELLINGTON MANAGEMENT GROUP LLP, and StepStone Group LP. This page lists 97 institutional shareholders reporting positions in this security for the Q3 2024 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.